Global Eye Tracking in Healthcare Market - 2025-2033

The global eye tracking in healthcare market reached US$ 802.87 million in 2024 and is expected to reach US$ 5,155.83 million by 2033, growing at a CAGR of 21.4 % during the forecast period of 2025-2033.

The global eye tracking in healthcare market leverages eye tracking technology to enhance various aspects of healthcare delivery, ranging from diagnostic tools to improving the user experience in medical devices and applications. Eye tracking measures the movement and focus of a person's eyes, providing valuable data for neurological assessments, cognitive disorder diagnoses, and rehabilitation therapy.

This technology is used to monitor eye movements for the detection of conditions such as stroke, dementia, and visual impairments, while also offering insights into mental health conditions like ADHD or autism spectrum disorders. By tracking where and how patients focus, healthcare professionals gain a deeper understanding of cognitive and neurological health, leading to more precise treatments and diagnoses.

Market Dynamics: Drivers & Restraints

Rising Prevalence of Neurological and Cognitive Disorders

The rising prevalence of neurological and cognitive disorders is a key driver in the global eye tracking in healthcare market. As neurological and cognitive conditions such as Alzheimer's disease, Parkinson's disease, stroke, and autism spectrum disorders (ASD) become more common, the demand for innovative diagnostic and monitoring tools, such as eye tracking technology, is increasing.

Eye tracking offers valuable insights into these disorders by analyzing eye movements, helping to identify early signs and aiding in more accurate diagnoses. For instance, the World Health Organization estimates that approximately 50 million people worldwide suffer from dementia, and the number is expected to rise to 82 million by 2030. Additionally, Parkinson's disease affects about 10 million people globally. These numbers underscore the urgent need for better diagnostic tools in the healthcare sector.

Eye tracking can play a critical role in assessing neurological function, detecting early changes in cognition, and offering a non-invasive way to monitor disease progression over time. As the global population ages and the incidence of cognitive disorders increases, eye tracking technology is becoming an essential tool for clinicians aiming to improve patient care and enhance treatment outcomes. All these factors demand global eye tracking in the healthcare market.

High Costs of Equipment and Implementation

The high costs of equipment and implementation pose a significant restraint in the global eye tracking in healthcare market, limiting the widespread adoption of this technology, especially in healthcare settings. Eye tracking systems, particularly those designed for medical diagnostics or neurological assessments, often involve high-end sensors, specialized software, and advanced hardware components that come at a steep price.

For instance, clinical-grade systems capable of detecting subtle eye movements associated with neurological diseases or cognitive disorders require significant investment in both equipment and the infrastructure to support them. The price range of $1.001 to $10,000 for eye tracking systems can act as a restraint in the global eye tracking in healthcare market because these systems, while suitable for certain applications, may not meet the precision and reliability standards required for more advanced healthcare diagnostics. Thus, the above factors could be limiting the global eye tracking in the healthcare market's potential growth.

Segment Analysis

The global eye tracking in healthcare market is segmented based on type, tracking type, component, application, end-user, and region.

Tracking Type:

The remote tracking segment in tracking type is expected to dominate the global eye tracking in healthcare market with the highest market share

The remote tracking segment of the global eye tracking in healthcare market leverages innovative technologies such as cloud computing, mobile devices, and wearable technologies to enable the monitoring of patients' eye movements outside traditional clinical settings.

This capability is crucial in telemedicine platforms, mobile health apps, and home-based monitoring systems. By allowing healthcare providers to track patients from a distance, remote eye tracking can be especially beneficial for continuous monitoring of those with neurological conditions, cognitive disorders, or individuals undergoing rehabilitation therapies.

It eliminates the need for patients to visit healthcare facilities regularly, improving access to care and enhancing patient convenience. This is especially important as patients, particularly those with chronic conditions, can experience fluctuations in symptoms that require consistent tracking.

By enabling eye movement analysis outside of medical environments, remote tracking technology offers greater flexibility in patient care and supports early detection of changes in cognitive or neurological health. It also allows for real-time data collection, making it easier to adjust treatment plans or interventions based on immediate insights. These factors have solidified the segment's position in the global eye tracking in healthcare market.

Geographical Analysis

North America is expected to hold a significant position in the global eye tracking in healthcare market, with the highest market share

The North American eye tracking in healthcare market is being driven by several factors. One of the key drivers is the increasing application of eye tracking technology in the healthcare sector, particularly for diagnosing and monitoring neurological disorders like Parkinson's disease, Alzheimer's, and other cognitive impairments. This technology provides valuable insights into eye movements and gaze patterns, which help in early detection and assessment, enhancing the effectiveness of treatment and rehabilitation.

Furthermore, North America's advanced healthcare system and technological infrastructure play a significant role in driving the market. The region is home to leading research institutions and healthcare providers that integrate eye tracking into clinical practices, such as in cognitive rehabilitation and assistive devices for patients with severe motor disabilities.

The region is also seeing increased adoption in consumer electronics, gaming, and the automotive industry, all of which are contributing to the broader use of eye tracking in healthcare settings. Thus, the above factors are consolidating the region's position as a dominant force in the global eye tracking in healthcare market.

Competitive Landscape

The major global players in the eye tracking in healthcare market include Tobii, SR Research Ltd., iMotions, Gazepoint, EyeTech Digital Systems, Inc., Pupil Labs GmbH, EyeTracking, Smart Eye, Lumen, and ERGONEERS GmbH, among others.

Key Developments

• In February 2024, Visage Imaging, Inc. unveiled the innovative Visage Ease VP for Apple Vision Pro, Apple's much-awaited spatial computing platform. Tailored to leverage the distinct features of Apple Vision Pro, Visage Ease VP enables immersive, spatial interactions for diagnostic imaging and multimedia applications.
• In January 2024, Tobii's launch of the UX Explore cloud platform, designed to enhance mobile user experience (UX) research with eye-tracking technology, is a significant development that could positively impact the global eye-tracking in healthcare market. This cloud-based solution allows for more scalable, efficient, and accessible UX research, enabling healthcare professionals and developers to evaluate the user experience of mobile healthcare applications, telemedicine platforms, and digital health devices with greater ease.

Why Purchase the Report?

• Pipeline & Innovations: Reviews ongoing clinical trials and product pipelines and forecasts upcoming advancements in medical devices and pharmaceuticals.
• Product Performance & Market Positioning: Analyzed product performance, market positioning, and growth potential to optimize strategies.
• Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
• Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
• Market Updates & Industry Changes: This covers recent regulatory changes, new policies, and emerging technologies.
• Competitive Strategies: Analyze competitor strategies, market share, and emerging players.
• Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
• Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
• Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
• Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
• Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
• Post-market Surveillance: Uses post-market data to enhance product safety and access.
• Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global eye tracking in healthcare market report delivers a detailed analysis with 78 key tables, more than 71 visually impactful figures, and 176 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2024

• Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
• Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
• Technology & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
• Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
• Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
• Supply Chain: Distribution and Supply Chain Managers.
• Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
• Academic & Research: Academic Institutions.